Cargando…

The problem is obtaining knowledge: a qualitative analysis of provider barriers and accelerators to rapid adoption of new treatment in a public health emergency

Granted by the U.S. Food and Drug Administration, an Emergency Use Authorization (EUA) can only be utilized upon declaration that a specialized set of circumstances exist which justify the authorization. In 2020, the COVID-19 pandemic demanded rapid communication strategies to promote treatment opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Stuart H., McFarlane, Megan D., Giammarino, Mary, Oleksa, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881294/
https://www.ncbi.nlm.nih.gov/pubmed/36707792
http://dx.doi.org/10.1186/s12889-022-14890-3